Effect of altered WIG-1 expression on DDP sensitivity in a DDP-Resistant Esophageal Squamous Cancer Cell Line

Current Cancer Drug Targets

Volumn 12, Issue 8, 2012, Pages 950-961

  Qiu, Yang ^a,b   Zou, Ying Bo ^a   Li, Kun ^a   Jiang, Yao Guang ^a   Yang, Kang ^b   Zhao, Yun Ping ^a   Guo, Wei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; DDP; Drug resistance; EC109; ESCC; WIG 1

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PROTEIN BAX; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WIDE TYPE P53 INDUCED GENE 1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867813105     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800912803251252     Document Type: Article

References (40)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA. Cancer J. Clin. 2008, 58, 71-96.
2. Pisani, P.; Parkin, D. M.; Bray, F.; Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 1999, 83, 18-29.
3. Daly, J. M.; Fry, W. A.; Little, A. G.; Winchester, D. P.; McKee, R. F.; Stewart, A. K.; Fremgen, A. M. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J. Am. Coll. Surg. 2000, 190, 562-572.
4. Enzinger, P. C.; Mayer, R. J. Esophageal cancer. N. Engl. J. Med. 2003, 349, 2241-52.
5. Quiros, R. M.; Bui, C. L. Multidisciplinary approach to esophageal and gastric cancer. Surg. Clin. North Am. 2009, 89, 79-96.
6. Herskovic, A.; Martz, K.; al-Sarraf, M.; Leichman, L.; Brindle, J.; Vaitkevicius, V.; Cooper, J.; Byhardt, R.; Davis, L.; Emami, B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 1992, 326, 1593-1598.
7. Szymkowski, D. E.; Yarema, K.; Essigmann, J. M.; Lippard, S. J.; Wood, R. D. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 10772-10776.
8. Gosland, M.; Lum, B.; Schimmelpfennig, J.; Baker, J.; Doukas, M. Insights into mechanisms of cisplatin resistance and potential for its clinical reversal. Pharmacotherapy 1996, 16, 16-39.
9. Varmeh-Ziaie, S.; Okan, I.; Wang, Y.; Magnusson, K. P.; Warthoe, P.; Strauss, M.; Wiman, K. G. WIG-1, a new p53-induced gene encoding a zinc finger protein. Oncogene 1997, 15, 2699-2704.
10. Hellborg, F.; Qian, W.; Mendez-Vidal, C.; Asker, C.; Kost-Alimova, M.; Wilhelm, M.; Imreh, S.; Wiman, K. G. Human WIG-1, a p53 target gene that encodes a growth inhibitory zinc finger protein. Oncogene 2001, 20, 5466-5474.
11. Israeli, D.; Tessler, E.; Haupt, Y.; Elkeles, A.; Wilder, S.; Amson, R.; Telerman, A.; Oren, M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO. J. 1997, 16, 4384-4392.
12. Vilborg, A.; Glahder, J. A.; Wilhelm, M. T.; Bersani, C.; Corcoran, M.; Mahmoudi, S.; Rosenstierne, M.; Grandér, D.; Farnebo, M.; Norrild, B.; Wiman, K. G. The p53 target WIG-1 regulates p53 mRNA stability through an AU-rich element. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 15756-15761.
13. Varmeh-Ziaie, S.; Ichimura, K.; Yang, F.; Rabbits, P.; Collins, V. P. Cloning and chromosomal localization of human WIG-1/PAG608 and demonstration of amplification with increased expression in primary squamous cell carcinoma of the lung. Cancer Lett. 2001, 174, 179-187.
14. Enge, M.; Bao, W.; Hedstrom, E.; Jackson, S. P.; Moumen, A.; Selivanova, G. MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53. Cancer Cell 2009, 15, 171-183.
15. Zou, Y. B.; Guo, W.; Jiang, Y. G.; Wang, R. W.; Zhao, Y. P.; Ma, Z. Preparation of a novel monoclonal antibody specific for WIG-1 and detection of its expression pattern in human esophageal carcinoma. Hybridoma (Larchmt) 2010, 29, 431-436.
16. Guo, W.; Zou, Y. B.; Jiang, Y. G.; Wang, R. W.; Zhao, Y. P.; Ma, Z. Zinc induces cell cycle arrest and apoptosis by upregulation of WIG-1 in esophageal squamous cancer cell line EC109. Tumour Biol. 2011, 32, 801-808.
17. Kutner, R. H.; Zhang, X. Y.; Reiser, J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 2009, 4, 495-505.
18. Mendez-Vidal, C.; Wilhelm, M. T.; Hellborg, F.; Qian, W.; Wiman, K. G. The p53-induced mouse zinc finger protein wig-1 binds double-stranded RNA with high affinity. Nucleic Acids Res. 2002, 30, 1991-1996.
19. Vousden, K. H.; Ryan, K. M. p53 and metabolism. Nat. Rev. Cancer 2009, 9, 691-700.
20. Vousden, K. H.; Prives, C. Blinded by the Light: The growing complexity of p53. Cell 2009, 137, 413-431.
21. Soussi, T.; Wiman, K. G. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 2007, 12, 303-312.
22. Brass, N.; Rácz, A.; Heckel, D.; Remberger, K.; Sybrecht, G. W.; Meese, E. U. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res. 1997, 57, 2290-2294.
23. Sattler, H. P.; Lensch, R.; Rohde, V.; Zimmer, E.; Meese, E.; Bonkhoff, H.; Retz, M.; Zwergel, T.; Bex, A.; Stoeckle, M.; Wullich, B. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate 2000, 45, 207-215.
24. Lazo, P. A. The molecular genetics of cervical carcinoma. Br. J. Cancer 1999, 80, 2008-2018.
25. Hibi, K.; Trink, B.; Patturajan, M.; Westra, W. H.; Caballero, O. L.; Hill, D. E.; Ratovitski, E. A.; Jen, J.; Sidransky, D. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 5462-5467.
26. Sugita, M.; Tanaka, N.; Davidson, S.; Sekiya, S.; Varella-Garcia, M.; West, J.; Drabkin, H. A.; Gemmill, R. M. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet. Cytogenet. 2000, 117, 9-18.
27. Vilborg, A.; Bersani, C.; Wilhelm, M. T.; Wiman, K. G. The p53 target Wig-1: a regulator of mRNA stability and stem cell fate? Cell Death Differ. 2011, 18, 1434-1440.
28. Kartalou, M.; Essigmann, J. M. Mechanisms of resistance to cisplatin. Mutat. Res. 2001, 478, 23-43.
29. Reardon, J. T.; Vaisman, A.; Chaney, S. G.; Sancar, A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-acetoamminedichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts. Cancer Res. 1999, 59, 3968-3971.
30. de Boer, J.; Hoeijmakers, J. H. Nucleotide excision repair and human syndromes. Carcinogenesis 2000, 21, 453-460.
31. Li, Q.; Yu, J. J.; Mu, C.; Yunmbam, M. K.; Slavsky, D.; Cross, C. L.; Bostick-Bruton, F.; Reed, E. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Anticancer Res. 2000, 20, 645-652.
32. Metzger, R.; Leichman, C. G.; Danenberg, K. D.; Danenberg, P. V.; Lenz, H. J.; Hayashi, K.; Groshen, S.; Salonga, D.; Cohen, H.; Laine, L.; Crookes, P.; Silberman, H.; Baranda, J.; Konda, B.; Leichman, L. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J. Clin. Oncol. 1998, 16, 309-316.
33. Welsh, C.; Day, R.; McGurk, C.; Masters, J. R.; Wood, R. D.; Köberle, B. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J. Cancer 2004, 110, 352-361.
34. Chang, I. Y.; Kim, M. H.; Kim, H. B.; Lee, D. Y.; Kim, S. H.; Kim, H. Y.; You, H. J. Small interfering RNAinduced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin. Biochem. Biophys. Res. Commun. 2005, 327, 225-233.
35. Reed, J. C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 1999, 17, 2941-2953.
36. Addeo, R.; Crisci, S.; D'Angelo, V.; Vincenzi, B.; Casale, F.; Pettinato, G.; Donofrio, V.; Boldrini, R.; Alaggio, R.; Collini, P.; Bertorelle, R.; Di Tullio, M. T.; Caraglia, M.; Terenziani, M.; Lo Curto, M.; Indolfi, P. Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors. Oncol. Rep. 2007, 17, 1155-1161.
37. Mancinelli, F.; Caraglia, M.; Budillon, A.; Abbruzzese, A.; Bismuto, E. Molecular dynamics simulation and automated docking of the pro-apoptotic Bax protein and its complex with a peptide designed from the Bax-binding domain of anti-apoptotic Ku70. J. Cell Biochem. 2006, 99, 305-318.
38. Magistrelli, P.; Coppola, R.; Tonini, G.; Vincenzi, B.; Santini, D.; Borzomati, D.; Vecchio, F.; Valeri, S.; Castri, F.; Antinori, A.; Nuzzo, G.; Caraglia, M.; Picciocchi, A. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma. J. Cell Biochem. 2006, 97, 98-108.
39. Chen, X.; Conti, P. S.; Moats, R. A. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004, 64, 8009-8014.
40. Yang, M.; Baranov, E.; Jiang, P.; Sun, F. X.; Li, X. M.; Li, L.; Hasegawa, S.; Bouvet, M.; Al-Tuwaijri, M.; Chishima, T.; Shimada, H.; Moossa, A. R.; Penman, S.; Hoffman, R. M. Wholebody optical imaging of green fluorescent protein-expressing tumors and metastases. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 1206-1211.